A giant leap forward in pharmaceutical and medical stocks in the hope context of COVID vaccine 19
The COVID-19 epidemic is spreading and hitting almost countries worldwide. To this day, the world has recorded more than 22 million cases of SARS-CoV-2 virus infection, nearly 800,000 people died.
In this context, the selection of investment stocks becomes more difficult, but not without opportunity. Instead of short-term transactions or surfing, the opportunities to invest in stock groups should have a vision from 6 months to 1 year. The stocks group during the COVID season is still a priority such as food or essential goods … and especially the pharmaceutical and medical stocks.
Last week, we saw many stocks falling deeply such as banking, aviation, and oil and gas, the big bright spot still belonged to pharmaceutical and medical stocks with the most prominent name is DNM when it jumped over 60% and many other codes also on the rise like DHT (+ 10.6%), IMP (+ 1.6%), TRA (+ 7.7%), PMC (+ 12.3%), PME ( +4.9%) … Easy to understand, on upbeat global market sentiment amid hopes of a potential coronavirus vaccine supply deal that Vietnamese shares extended gains on Thursday.
The VN-Index on the Hồ Chí Minh Stock exchange rose 0.96 percent to end the session at 855.05 points.
It had risen 0.46 percent to end Wednesday’s session at 846.92 points.
More than 256.2 million shares were traded on the southern exchange, worth VNĐ4.5 trillion (US$195 million).
Market breadth was positive with 294 gainers and 95 decliners.
Not only did domestic pharmaceutical and medical stocks surged, but Asia’s stock markets also followed Wall Street upwards on Thursday after information that the US government has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential COVID-19 vaccine.
MSCI’s broadest index of Asia-Pacific shares outside Japan rose 0.2 percent on Thursday.
President Vladimir Putin also announced Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing.
More than 100 possible COVID-19 vaccines are being developed around the world. At least four are in final Phase III human trials, according to the World Health Organization’s data.
Medical equipment company shares rose 5,000%
At the beginning of the year, before the COVID-19 translation broke out, the shares of Medtecs International Corp. – a medical clothing manufacturer based in Taipei (Taiwan) – traded for less than S $ 1 (SGD). Now, however, their value has increased by nearly 5,000%.
Medtecs International Corp’s net profit in the first half of 2020 increased about 100 times over the same period last year. This is explained by the abnormally increased demand for reusable hospital essentials, disposable personal protective equipment, and workwear.
Over the past time, the domestic and world economies have been “hit” by the COVID-19 pandemic. The epidemic has profoundly affected the socio-economic life of most countries. According to forecasts of the World Bank (WB), the global economy this year will decline seriously at 5.2%.
The COVID-19 pandemic crisis has affected the countries economy. However, in this context, according to the observer, it seems that only the pharmaceutical industry and medical equipment still perform well, even bring high profits when the demand for drugs, vaccines for treatment. COVID-19 as well as medical protective equipment is increasing.
Please do not hesitate to contact us for more information to be supported and consulted:
LUAT SU RIENG (LSR) LAW FIRM
Address: no. 16 Nguyen Quy Canh Street, An Phu Ward, District 2, Ho Chi Minh City
Hotline: 1900252503. Press No. 8
Email: i[email protected]